Afamelanotide, sold under the brand name Scenesse, is a medication used to prevent phototoxicity and to reduce pain from light exposure for people with...
25 KB (1,891 words) - 06:11, 26 April 2024
lobe of the pituitary gland. Synthetic analogues of α-MSH, such as afamelanotide (melanotan I; Scenesse), melanotan II, and bremelanotide (PT-141), have...
10 KB (940 words) - 05:25, 31 October 2023
effects against ultraviolet (UV) radiation from the sun. They include afamelanotide (melanotan) and melanotan II, the former of which has been approved...
8 KB (456 words) - 09:21, 24 July 2023
nausea and vomiting. As a tanning agent, melanotan I (now known as afamelanotide) was licensed by Competitive Technologies, a technology transfer company...
17 KB (1,327 words) - 19:26, 14 May 2024
other peptide analogues of the same family as bremelanotide include afamelanotide (NDP-α-MSH), modimelanotide, and setmelanotide. Studies in the early...
25 KB (2,118 words) - 22:18, 15 May 2024
and racist antics in nearly every episode. As of July 2013[update], afamelanotide is in phase II and III clinical trials for vitiligo and other skin diseases...
37 KB (3,797 words) - 20:49, 26 May 2024
Retrieved 2020-09-24. "Scenesse (afamelanotide) for adults with a history of phototoxic reactions from EPP". SCENESSE® (Afamelanotide). Retrieved 2020-09-24. Kraemer...
31 KB (2,997 words) - 01:57, 23 May 2024
Melanotan may refer to one of two separate peptides: Afamelanotide, originally developed under the names "Melanotan", "Melanotan-1", or "Melanotan I"...
622 bytes (120 words) - 11:29, 26 August 2021
peptide and agouti-related peptide, and activated by synthetic (i.e. afamelanotide) and endogenous agonist melanocyte-stimulating hormones. Several selective...
10 KB (1,143 words) - 18:46, 8 November 2023
several analogs, including afamelanotide, then called melanotan-I. In the European Union and United States, afamelanotide is indicated for the prevention...
37 KB (4,199 words) - 02:09, 31 May 2024
approved for chronic weight management in patients with genetic obesity. Afamelanotide (Scenesse) is an MC1R agonist approved for patients with erythropoietic...
12 KB (1,639 words) - 01:40, 18 December 2023
Melanocortin receptor modulators MC1 Agonists: ACTH (corticotropin) Afamelanotide (melanotan I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan...
16 KB (1,705 words) - 21:17, 17 May 2024
Unless there is liver failure, it is not a life-threatening disease. Afamelanotide, developed by Australian-based Clinuvel Pharmaceuticals, was approved...
25 KB (2,805 words) - 02:02, 28 May 2024
should suggest likely mechanisms of this interaction.[citation needed] Afamelanotide Agouti-related peptide Melanocortin Melanotan II GRCh38: Ensembl release...
20 KB (2,285 words) - 22:40, 14 May 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
50 KB (4,374 words) - 15:14, 13 May 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
22 KB (1,841 words) - 22:50, 30 April 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
187 KB (18,318 words) - 01:32, 24 May 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
68 KB (7,160 words) - 18:52, 24 February 2024
although long-term results are not yet available. In December 2014, afamelanotide received authorization from the European Commission as a treatment for...
64 KB (6,616 words) - 08:39, 2 June 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
34 KB (3,419 words) - 18:34, 9 June 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
23 KB (2,330 words) - 16:48, 11 May 2024
D02BA01 Aminobenzoic acid D02BA02 Octinoxate D02BB01 Betacarotene D02BB02 Afamelanotide "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis"...
1 KB (178 words) - 06:23, 19 February 2020
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
48 KB (4,530 words) - 17:50, 27 April 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
50 KB (5,401 words) - 02:51, 14 May 2024
Melanocortin receptor modulators MC1 Agonists: ACTH (corticotropin) Afamelanotide (melanotan I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan...
18 KB (1,407 words) - 04:49, 3 March 2024
Aeroseb-Dex Aeroseb-HC Aerosporin afacifenacine (INN) afalanine (INN) afamelanotide (INN) afatinib (INN, (USAN) Afaxin afegostat (USAN, INN) afelimomab...
5 KB (345 words) - 06:25, 1 June 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
91 KB (9,169 words) - 15:38, 18 May 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
74 KB (7,440 words) - 21:41, 12 June 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
199 KB (19,821 words) - 00:36, 2 June 2024
hydrocortisone) Skin lightening Hydroquinone Mequinol Monobenzone Skin darkening Afamelanotide Melanotan II Anti-inflammatories Oxaceprol Gamolenic acid Pimecrolimus...
216 KB (21,601 words) - 20:04, 23 February 2024